1. Home
  2. CURI vs ACHV Comparison

CURI vs ACHV Comparison

Compare CURI & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CuriosityStream Inc.

CURI

CuriosityStream Inc.

HOLD

Current Price

$2.46

Market Cap

187.9M

ML Signal

HOLD

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$5.38

Market Cap

172.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CURI
ACHV
Founded
N/A
N/A
Country
United States
United States
Employees
42
N/A
Industry
Movies/Entertainment
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
187.9M
172.0M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
CURI
ACHV
Price
$2.46
$5.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$5.83
$14.67
AVG Volume (30 Days)
326.2K
1.9M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
10.36%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.91
N/A
Revenue Next Year
$12.91
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.81
$2.00
52 Week High
$7.15
$6.15

Technical Indicators

Market Signals
Indicator
CURI
ACHV
Relative Strength Index (RSI) 29.55 61.69
Support Level N/A $4.04
Resistance Level $3.56 $5.90
Average True Range (ATR) 0.17 0.37
MACD -0.05 0.11
Stochastic Oscillator 15.64 63.45

Price Performance

Historical Comparison
CURI
ACHV

About CURI CuriosityStream Inc.

CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. The firm's products and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, and Others. The majority of the revenue comes from the direct business and Content licensing. Geographically, the company generates the majority of its revenue from the United States.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: